首頁 > 市場調查報告書 > 食物/飲料

機能性食品

市場調查報告書

商品編碼

1512667

全球腸道健康益生菌補充品市場 - 2024-2031

Global Gut Health Probiotic Supplements Market - 2024-2031

出版日期: 2024年07月10日 | 出版商:

DataM Intelligence | 英文 235 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

全球腸道健康益生菌補充劑市場在 2023 年達到 48 億美元，預計到 2031 年將達到 104 億美元，2024-2031 年預測期間複合年成長率為 11.1%。

健康意識的提高、人口老化和生活方式的改變影響消化健康並導致各種疾病。由於消費者對益生菌相關消化健康益處的認知不斷提高，全球腸道健康益生菌補充劑市場一直在穩步擴大。隨著人們越來越意識到維持健康的消化系統對整體健康的重要性，消費者對腸道健康的關注推動了市場的成長。

消費者更喜歡益生菌來應對各自的特定健康狀況。 2022 年，CRN 報告稱，特種補充劑的使用量增加。超過一半的補充劑消費者 (52%) 將特殊補充劑納入他們的系統中，最常用的類型包括 omega-3、益生菌、褪黑激素和纖維。

北美地區對消化保健品的高需求佔據市場主導地位。據 NIH 稱，美國約有 6,000 至 7,000 萬人患有消化系統疾病。負責任營養委員會於 2022 年 8 月進行的調查顯示，在 3,133 名 18 歲及以上的美國成年人中，其中 2,342 名成年人表示自己偶爾、定期或季節性地使用膳食補充劑。

動力學

消費者健康意識不斷增強

隨著消化和腸道健康問題的日益普遍，對具有健康益處的產品的需求不斷增加。據美國國立衛生研究院稱，一項利用網路調查進行的綜合性跨國研究發現，全球超過 40% 的人口存在胃腸道問題。據報道，腹瀉、便秘或腸躁症 (IBS) 的盛行率分別為 4.7%、11.7% 和 4.1%。

在預防健康問題和提高生活品質的願望的推動下，消費者越來越主動地尋求支持消化健康的產品。益生菌補充劑含有已知可支持腸道菌叢平衡和消化功能的有益細菌，作為實現這些健康目標的便捷有效方式，越來越受歡迎，推動了市場成長。

增加消費者益生菌的消費

消費者越來越意識到益生菌的健康益處，例如改善消化健康和免疫功能。人們越來越關注預防性醫療保健和整體健康，導致消費者尋求支持腸道健康的產品。益生菌被認為是天然有效的補充劑，可以促進健康的消化系統。

國際食品資訊理事會2021 年進行的一項調查顯示，51% 的美國人將益生菌納入飲食中以促進腸道健康，33% 的美國人將益生菌用於增強免疫功能，38% 的美國人將益生菌用於整體健康和保健目的， 13% 的人表示食用益生菌是為了支持情緒健康。益生菌補充劑的更多使用正在同時擴大市場成長。

缺乏消費者意識

許多消費者沒有意識到腸道健康狀況不佳會帶來健康後果，例如心臟病、中風和失智症的風險增加。 MDVIP 調查顯示，五分之三的美國人不知道不健康的腸道會增加心臟病、中風和失智症的風險。三分之二的美國人患有腸道問題，卻沒有意識到其健康後果。

這種認知的缺乏可能會導致對腸道健康產品（包括益生菌補充劑）的需求下降。如果不清楚益生菌如何促進消化健康、免疫功能和整體健康，消費者可能不會認為這些補充劑是必要的或有益的。這限制了市場成長潛力。

Rising health consciousness, ageing populations, and lifestyle changes impact digestive health and lead to various disorders. The global gut health probiotic supplements market has been expanding steadily, driven by increasing consumer awareness of the digestive health benefits associated with probiotics. With increasing awareness about the importance of maintaining a healthy digestive system for overall well-being, consumer focus on gut health drives market growth.

Consumers prefer probiotics to deal with respective and specific health conditions. In 2022, CRN reported that there had been a rise in the usage of speciality supplements. Over half of the supplement, consumers (52%) incorporate specialty supplements into their system, with the most commonly used types including omega-3s, probiotics, melatonin and fiber.

North America dominates the market with the high demand for digestive health care products. According to NIH, around 60 to 70 million people in the U.S. live with a digestive disease. The Council for Responsible Nutrition surveyed in August 2022 and stated that among 3,133 U.S. adults aged 18 and older, including 2,342 adults they indicated they use dietary supplements occasionally, regularly, or seasonally.

Dynamics

Growing Health Consciousness Among Consumers

With the increasing prevalence of digestive and gut health problems, there is increasing demand for products that provide health benefits. According to the National Institute of Health, in a comprehensive multinational study using internet surveys, it was found that over 40% of the global population experiences gastrointestinal issues. The prevalence rates of diarrhea, constipation, or irritable bowel syndrome (IBS), were reported to be 4.7%, 11.7%, and 4.1%, respectively.

Consumers are becoming more proactive in seeking products that support digestive health, driven by a desire to prevent health issues and enhance their quality of life. Probiotic supplements, which contain beneficial bacteria known to support gut flora balance and digestive function, are gaining popularity as a convenient and effective way to achieve these health goals, driving market growth.

Increasing Consumer Probiotics Consumption

Consumers are becoming more aware of the health benefits associated with probiotics, such as improved digestive health and immune function. There is a growing focus on preventive healthcare and overall wellness, leading consumers to seek products that support gut health. Probiotics are perceived as natural and effective supplements that can promote a healthy digestive system.

In a 2021 survey conducted by the International Food Information Council, findings indicated that 51% of Americans incorporate probiotics into their diets to promote gut health, 33% use them to bolster immune function, 38% integrate probiotics for overall health and wellness purposes, and 13% reported consuming probiotics to support emotional well-being. The higher use of probiotic supplements is parallelly expanding market growth.

Lack of Consumer Awareness

Many consumers are unaware of the health consequences associated with poor gut health, such as increased risks of heart attack, stroke, and dementia. MDVIP survey shows 3 in 5 Americans don't know an unhealthy gut can increase heart attack, stroke and dementia risk. Two-thirds of Americans are living with gut issues, unaware of the health consequences.

This lack of awareness can lead to lower demand for gut health products, including probiotic supplements. Without a clear understanding of how probiotics can contribute to digestive health, immune function, and overall well-being, consumers may not perceive these supplements as essential or beneficial. This limits market growth potential.

Segment Analysis

The global gut health probiotic supplements market is segmented based on strain, form, distribution channel, age group, application and region.

Increasing Prevalence of Specific Health Conditions

The global gut health probiotic supplements market is segmented based on application into general digestive health, specific health conditions and others. The specific health conditions segment accounted for the largest share of the global market. Irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) are some of the specific digestive health conditions that are commonly seen globally.

According to the International Foundation for Gastrointestinal Disorders, the worldwide estimation of IBS is reported to be 5-10% of the population. Similarly, in September 2023, results from a new study by Cedars-Sinai investigators revealed that irritable bowel syndrome is more prevalent than their previous estimation. The increasing prevalence of specific health conditions and the high prevalence of consumer willingness to take up natural curing measures drive segment growth.

Geographical Penetration

High Prevalence of Irritable Bowel Syndrome in North America

North America dominates the global gut health probiotic supplements market. North America, particularly United States and Canada, has a substantial population that is health-conscious and actively seeks preventive healthcare solutions. This strong cultural emphasis on health and wellness leads to a robust demand for products that support digestive health and overall well-being.

The high use of probiotic supplements in various aspects of application in North America is positively improving the market expansion in this region. According to the Food and Health Survey conducted by the International Food Information Council in April 2022, around 33% of respondents in United States try to include probiotics in their diets, with 60% aiming to do so daily.

North America's dominance in the global gut health probiotic supplements market is high due to the consumer interest in health and wellness and also advancements in product development. The region is a hub for research and innovation in healthcare and nutrition, fostering the development of advanced probiotic formulations and technologies along with the presence of leading global manufacturers.

Competitive Landscape

The major global players in the market include The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited, Unique Biotech Limited, Projoy Pvt Ltd, Nature's Bounty, Hyperbiotics, Advanced Vital Enzymes Private Ltd, Wren Laboratories Ltd and Nordic Naturals.

COVID-19 Impact Analysis

COVID-19 had a moderate impact on the global gut health probiotic supplements market. Initially, the market faced disruptions in raw material supply chains and manufacturing capabilities due to lockdowns and restrictions on movement. Some supplement manufacturers faced challenges in maintaining production levels and ensuring timely distribution due to logistical issues and workforce constraints.

The pandemic heightened awareness of the importance of immune health. Probiotics are known to support gut health, which in turn can influence immune function. This awareness may drive long-term demand for gut health supplements. With lockdowns and social distancing measures, there was a significant shift towards online shopping. This trend benefited e-commerce channels for supplement sales, allowing companies to reach consumers directly.

By Strain

Lactobacillus
Bifidobacterium
Streptococcus
Other

By Form

Tablet
Capsules
Liquid
Powder
Others

By Distribution Channel

Pharmacies/Drugstores
Specialty Stores
Online Retail
Other

By Age-Group

Children
Adults
Seniors

By Application

General Digestive Health
Specific Health Conditions
- Irritable Bowel Syndrome (IBS)
- Inflammatory Bowel Disease (IBD)
Other

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Russia
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

In August 2023, Hyperbiotics introduced PRO-IBS Support. This innovative product features a dual-action synergistic blend of Lactiplantibacillus plantarum 299v and highly bioavailable Boswellia serrata extract. The formulation aims to effectively alleviate gut discomfort and dysfunction in individuals with IBS.
In August 2022, researchers at the University of Nottingham secured £1.8 million in funding for a three-year project to explore the potential benefits of cellulose-based food supplements for individuals suffering from Irritable Bowel Syndrome, focusing on colon fermentation.

Why Purchase the Report?

To visualize the global gut health probiotic supplements market segmentation based on strain, form, distribution channel, age group, application and region, as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of gut health probiotic supplements market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global gut health probiotic supplements market report would provide approximately 78 tables, 74 figures and 235 pages.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Strain
3.2. Snippet by Form
3.3. Snippet by Distribution Channel
3.4. Snippet by Age Group
3.5. Snippet by Application
3.6. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Health Consciousness Among Consumers
  - 4.1.1.2. Increasing Consumer Probiotics Consumption
- 4.1.2. Restraints
  - 4.1.2.1. Lack of Consumer Awareness
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Strain

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
- 7.1.2. Market Attractiveness Index, By Strain
7.2. Lactobacillus
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bifidobacterium
7.4. Streptococcus
7.5. Other

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Tablet
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Liquid
8.5. Powder
8.6. Others

9. By Distribution Channel

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Pharmacies/Drugstores
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Stores
9.4. Online Retail
9.5. Other

10. By Age Group

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 10.1.2. Market Attractiveness Index, By Age Group
10.2. Children
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Adults
10.4. Seniors

11. By Application

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.1.2. Market Attractiveness Index, By Application
11.2. General Digestive Health
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Specific Health Conditions
- 11.3.1. Irritable Bowel Syndrome (IBS)
- 11.3.2. Inflammatory Bowel Disease (IBD)
11.4. Other

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.8.1. U.S.
  - 12.2.8.2. Canada
  - 12.2.8.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.8.1. Germany
  - 12.3.8.2. U.K.
  - 12.3.8.3. France
  - 12.3.8.4. Italy
  - 12.3.8.5. Spain
  - 12.3.8.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.8.1. Brazil
  - 12.4.8.2. Argentina
  - 12.4.8.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.8.1. China
  - 12.5.8.2. India
  - 12.5.8.3. Japan
  - 12.5.8.4. Australia
  - 12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. The Good Bug
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. Zeroharm Sciences Private Limited
14.3. Menoveda Life Sciences Private Limited
14.4. Unique Biotech Limited
14.5. Projoy Pvt Ltd
14.6. Nature's Bounty
14.7. Hyperbiotics
14.8. Advanced Vital Enzymes Private Ltd
14.9. Wren Laboratories Ltd
14.10. Nordic Naturals

LIST NOT EXHAUSTIVE